<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01113359</url>
  </required_header>
  <id_info>
    <org_study_id>BJCY-CV-2010001</org_study_id>
    <secondary_id>YXinchun</secondary_id>
    <nct_id>NCT01113359</nct_id>
  </id_info>
  <brief_title>The Link Between Human Cytomegalovirus (HCMV) and Hypertension</brief_title>
  <official_title>The Potential Link Between HCMV Infection and Essential Hypertension</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Chao Yang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Chao Yang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      It has been reported that mouse cytomegalovirus infection alone can elevate the blood&#xD;
      pressure in mice. Since HCMV has uniquely evolved with its human host, with little genetic&#xD;
      similarity to the animal CMV counterparts, and it only replicates in human, an&#xD;
      epidemiological study is required to define the relevance of HCMV infection and expression of&#xD;
      hcmv-miRNA-UL112 to the pathogenesis of essential hypertension.&#xD;
&#xD;
      The investigators found that hcmv-miR-UL112, a human cytomegalovirus (HCMV)-encoded miRNA,&#xD;
      was highly expressed in the hypertensive patients. Among the top miRNA target predictions,&#xD;
      the investigators demonstrate that IRF-1 is a direct target gene of hcmv-miR-UL112, along&#xD;
      with MICB that has been previously reported. Both IRF-1 and MICB play critical roles in&#xD;
      immuno/inflammatory and anti-infection response. Thus, the investigators speculated that&#xD;
      IRF-1 and MICB repression by hcmv-miR-UL112 could be considered a unifying mechanism that&#xD;
      evades the host response at several levels: antiviral, inflammatory, and immune. In addition,&#xD;
      there is an increasing evidence that IRF-1 may be important in apoptosis, angiogenesis,&#xD;
      neointima formation and the pathogenesis of vascular diseases. IRF-1 can up-regulate&#xD;
      angiotensin II type 2 receptor (AGTR2) that exerts antiproliferative and proapoptotic actions&#xD;
      and affects regulation of blood pressure. It has been reported that the targeted disruption&#xD;
      of the mouse AGTR2 gene resulted in a significant increase in blood pressure and increased&#xD;
      sensitivity to angiotensin II. The nitric oxide synthase expression and NO synthesis in&#xD;
      macrophages and distinct cardiomyocytes are induced and controlled by IRF-1 in response to&#xD;
      inflammation, important steps in vascular biology that may improve endothelial function and&#xD;
      inhibit smooth muscle cell migration, and a key pathophysiological event in hypertension.&#xD;
      Collectively, these reports support a strong relationship between IRF-1 regulation and&#xD;
      hypertension, indicating a potential role of hcmv-miR-UL112 and HCMV infection in the&#xD;
      pathogenesis of hypertension.Thus, the investigators want to investigate the potential link&#xD;
      between HCMV infection and essential hypertension.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>April 2010</start_date>
  <completion_date type="Anticipated">May 2010</completion_date>
  <primary_completion_date type="Anticipated">May 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>The positive rate of HCMV infection in hypertensive patients and healthy control</measure>
    <time_frame>1 month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>HCMV copies number per ml plasma of hypertensive patients and healthy controls</measure>
    <time_frame>1 month</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>HCMV Infection</condition>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>study group</arm_group_label>
    <description>hypertensive patients</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <description>healthy volunteer</description>
  </arm_group>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        essential hypertensive patients:&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with essential hypertension are assessed for potential secondary causes, for&#xD;
             the severity of hypertension, other risk factors and for end-organ damage&#xD;
&#xD;
          -  Aged between 30 to 60 years&#xD;
&#xD;
          -  Untreated (whole day average &gt; 140/90 mmHg) or treated hypertension whole-day average&#xD;
             &lt; 140/85), as determined by 24-hour blood pressure monitoring.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cancer&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Smoking&#xD;
&#xD;
          -  Renal failure&#xD;
&#xD;
          -  Stroke&#xD;
&#xD;
          -  Peripheral artery disease&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xin-Chun Yang, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beijing Chao Yang Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Jun Cai</name>
      <address>
        <city>Beijing</city>
        <state>Chaoyang</state>
        <zip>100020</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jun Cai, MD</last_name>
      <phone>+86 10 85231217</phone>
      <email>caijun7879@yahoo.com.cn</email>
    </contact>
    <investigator>
      <last_name>Jun Cai, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <study_first_submitted>April 27, 2010</study_first_submitted>
  <study_first_submitted_qc>April 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 29, 2010</study_first_posted>
  <last_update_submitted>April 28, 2010</last_update_submitted>
  <last_update_submitted_qc>April 28, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Jun Cai / Heart Center</name_title>
    <organization>Beijing Chao Yang Hospital</organization>
  </responsible_party>
  <keyword>HCMV infection</keyword>
  <keyword>Hypertension</keyword>
  <keyword>The Potential Link Between HCMV Infection and Essential Hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Cytomegalovirus Infections</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Essential Hypertension</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

